FIBROGEN INC Contracts & Agreements

90 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
FIBROGEN, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 09, 2014 APPROVED BY THE STOCKHOLDERS:SEPTEMBER 30, 2014 IPO DATE/EFFECTIVE DATE:[ ], 2014
Bonus & Incentive Agreements
FIBROGEN INC
Biotechnology
DE
2014
First Amended and Restated Evaluation Agreement by and between FibroGen, Inc. and Fortis Therapeutics, Inc., dated June 6, 2024
FIBROGEN INC
2024
FibroGen, Inc. 2024 Equity Incentive Plan
Bonus & Incentive Agreements
FIBROGEN INC
2024
Amendment No. 1 to the Exclusive License and Option Agreement, between FibroGen, Inc. and HiFiBiO Inc., dated February 14, 2024
License Agreements
FIBROGEN INC
2024
Termination and Transition Agreement to Development and Commercialization Agreement (for the U.S. and Certain Other Territories), by and between AstraZeneca AB and FibroGen, Inc.,...
Transition Agreements
FIBROGEN INC
2024
Non-Employee Director Compensation Policy, as amended, dated April 22, 2024
Compensation Agreements
FIBROGEN INC
2024
Offer Letter by and between FibroGen, Inc. and Deyaa Adib, M.D., dated February 6, 2024
FIBROGEN INC
2024
FibroGen, Inc. Bonus Plan
Bonus & Incentive Agreements
FIBROGEN INC
2024
Amendment No. 1 to the Second Amended and Restated Exclusive License Agreement, dated as of November 16, 2023
License Agreements
FIBROGEN INC
2024
Consulting Agreement, dated September 11, 2023, between FibroGen, Inc. and Mark Eisner
Consulting Agreements
FIBROGEN INC
2023
Amended and Restated Exclusive License Agreement by and among FibroGen, Inc., FibroGen (China) Medical Technology Development Co., Ltd., and Eluminex Biosciences Suzhou) Limited,...
License Agreements
FIBROGEN INC
2023
Offer Letter, dated July 23, 2023, between FibroGen, Inc. and Thane Wettig
FIBROGEN INC
2023
Consulting Agreement, dated July 23, 2023, between FibroGen, Inc. and Enrique Conterno
Consulting Agreements
FIBROGEN INC
2023
Amended and Restated Exclusive License Agreement by and between FibroGen, Inc. and Eluminex Biosciences (Suzhou) Limited as of January 21, 2022
License Agreements
FIBROGEN INC
Biotechnology
NY
2022
Amendment No. 4 to Master Supply Agreement by and among FibroGen, Inc., Shanghai SynTheAll Pharmaceutical Co., Ltd., and STA Pharmaceutical Hong Kong Limited, dated as of October...
Supply Agreements
FIBROGEN INC
2022
Transition Agreement by and between FibroGen, Inc. and Pat Cotroneo, dated as of August 14, 2021
Transition Agreements
FIBROGEN INC
Biotechnology
CA
2021
Exclusive License Agreement by and between FibroGen, Inc. and Eluminex Biosciences (Suzhou) Limited as of July 16, 2021
License Agreements
FIBROGEN INC
2021
Offer Letter by and between FibroGen, Inc. and Juan Graham, effective as of July 30, 2021
FIBROGEN INC
Biotechnology
2021
Sixth Amendment to the Lease by and between ARE-San Francisco No., 43, LLC and FibroGen, Inc. as of June 1, 2021
Lease Agreements
FIBROGEN INC
Biotechnology
2021
Exclusive License and Option Agreement by and between FibroGen, Inc. and HiFiBiO (HK) Limited (D.B.A. HiFiBiO Therapeutics), as of June 16, 2021
License Agreements
FIBROGEN INC
2021
Transition, Separation, and Consulting Agreement by and between FibroGen, Inc. and K. Peony Yu, dated as of November 27, 2020
Consulting Agreements
FIBROGEN INC
2021
Astellas EU Supply Agreement by and between FibroGen, Inc. and Astellas Pharma Europe Ltd, effective as of January 1, 2021
Supply Agreements
FIBROGEN INC
2021
Amendment No. 3 to Master Supply Agreement by and among FibroGen, Inc., Shanghai SynTheAll Pharmaceutical Co., Ltd., and STA Pharmaceutical Hong Kong Limited, dated as of January...
Supply Agreements
FIBROGEN INC
2021
Master Services Agreement by and between FibroGen, Inc. and Samsung Biologics Co., Ltd., effective as of October 30, 2020
Services Agreements
FIBROGEN INC
Biotechnology
IL
2021
Product Specific Agreement by and between FibroGen, Inc. and Samsung Biologics Co., Ltd., effective as of October 30, 2020
FIBROGEN INC
2021
Offer Letter, by and between FibroGen, Inc. and Mark Eisner, dated as of October 22, 2020
FIBROGEN INC
Biotechnology
2021
Collaboration Agreement by and between FibroGen, Inc. and Astellas Pharma Inc., effective June 1, 2005
Collaboration Agreements
FIBROGEN INC
Biotechnology
CA
2020
Amendment No. 1 to Master Supply Agreement by and among FibroGen, Inc., Shanghai SynTheAll Pharmaceutical Co., Ltd. and STA Pharmaceutical Hong Kong Limited, effective as of May...
Supply Agreements
FIBROGEN INC
2020
Amendment No. 1 to the Amended and Restated License, Development and Commercialization Agreement by and between FibroGen, Inc. and AstraZeneca AB, effective as of July 1, 2020
License Agreements
FIBROGEN INC
2020
Second Amended and Restated License, Development and Commercialization Agreement by and among FibroGen China Anemia Holdings, Ltd., FibroGen China Medical Technology Development...
License Agreements
FIBROGEN INC
2020
Offer Letter, by and between FibroGen, Inc. and Thane Wettig, dated as of May 7, 2020
FIBROGEN INC
Biotechnology
2020
FibroGen, Inc. Non-Employee Director Compensation Policy, as amended
Compensation Agreements
FIBROGEN INC
Biotechnology
2020
Form of Executive Officer Change in Control and Severance Agreement
Change of Control Agreements
FIBROGEN INC
2020
Offer Letter, by and between FibroGen, Inc. and Enrique Conterno, dated as of December 17, 2019
FIBROGEN INC
2020
Offer Letter, by and between FibroGen, Inc. and Elias Kouchakji, dated as of January 24, 2014
FIBROGEN INC
Biotechnology
2020
Offer Letter, by and between FibroGen, Inc. and Christine Chung, dated as of June 17, 2008
FIBROGEN INC
2020
Commercial Supply Agreement by and between FibroGen, Inc. and Catalent Pharma Solutions, LLC, effective as of January 1, 2020
Supply Agreements
FIBROGEN INC
2020
Description of Capital Stock of FibroGen, Inc
Stock Agreements
FIBROGEN INC
2020
Offer Letter, by and between FibroGen, Inc. and James Schoeneck, dated September 18, 2019
FIBROGEN INC
Biotechnology
2019
FibroGen, Inc. Non-Employee Director Compensation Policy, as amended
Compensation Agreements
FIBROGEN INC
Biotechnology
2019
FibroGen, Inc. Non-Employee Director Compensation Policy, as amended
Compensation Agreements
FIBROGEN INC
Biotechnology
2019
Amendment No. 33 to the Process Development and Clinical Supply Agreement, by and between FibroGen, Inc. and Boehringer Ingelheim Biopharmaceuticals GmbH, effective as of January...
Development Agreements
FIBROGEN INC
2019
Amendment No. 1 to Collaboration Agreement, by and between FibroGen, Inc. and Astellas Pharma Inc., effective as of January 1, 2013
Collaboration Agreements
FIBROGEN INC
Biotechnology
2019
FibroGen, Inc. Non-Employee Director Compensation Policy, as amended
Compensation Agreements
FIBROGEN INC
Biotechnology
2018
Materials Transfer Agreement Letter to Astellas Pharma Inc., dated June 15, 2018
FIBROGEN INC
2018
Preapproval Transfer Price Letter to Astellas Pharma Inc., dated June 15, 2018
FIBROGEN INC
Biotechnology
2018
Amendment No. 32 to the Process Development and Clinical Supply Agreement, by and between FibroGen, Inc. and Boehringer Ingelheim Biopharmaceuticals GmbH, effective as of...
Development Agreements
FIBROGEN INC
Biotechnology
2018
Work Order No. 1 to the Process Development and Clinical Supply Agreement, by and between FibroGen, Inc. and Boehringer Ingelheim Biopharmaceuticals GmbH, effective as of...
Development Agreements
FIBROGEN INC
Biotechnology
2018
Bonus Plan, adopted February 13, 2018
Bonus & Incentive Agreements
FIBROGEN INC
2018
Shareholders Agreement by and among FibroGen International (Cayman) Limited and certain of its shareholders, dated as of September 8, 2017
Shareholders Agreements
FIBROGEN INC
Biotechnology
DE
2017
Collaboration Agreement, by and between FibroGen, Inc. and Astellas Pharma Inc., effective as of June 1, 2005
Collaboration Agreements
FIBROGEN INC
2017
FibroGen,Inc. Common Stock, par value $0.01 per share Underwriting Agreement
Underwriting Agreements
FIBROGEN INC
2017
FIBROGEN, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENT
Change of Control Agreements
FIBROGEN INC
2017
State-Owned Construction Land Use Right Granting Contract Promulgated by Ministry of Land and Resources of the Peoples Republic of China State Administration for Industry and...
Administration Agreements
FIBROGEN INC
Biotechnology
2017
Amendment No. 31 to the Process Development and Clinical Supply Agreement
Development Agreements
FIBROGEN INC
Biotechnology
2017
FibroGen,Inc. Common Stock, par value $0.01 per share Underwriting Agreement
Underwriting Agreements
FIBROGEN INC
2017
Amendment No. 30 to the Process Development and Clinical Supply Agreement
Development Agreements
FIBROGEN INC
Biotechnology
2017
Amendment No. 29 to the Process Development and Clinical Supply Agreement
Development Agreements
FIBROGEN INC
2017
Exhibit A Work Scope [*] (Version of June 8, 2016) [*]
FIBROGEN INC
2016
Exhibit A Work Scope [*] (Version of August 31, 2016) [*]
FIBROGEN INC
2016
Amendment No. 26 to the Process Development and Clinical Supply Agreement
Development Agreements
FIBROGEN INC
Biotechnology
2016
Amendment No. 25 to the Process Development and Clinical Supply Agreement
Development Agreements
FIBROGEN INC
Biotechnology
2016
Amendment No. 24 to the Process Development and Clinical Supply Agreement
Development Agreements
FIBROGEN INC
2016
Amendment No. 22 to the Process Development and Clinical Supply Agreement
Development Agreements
FIBROGEN INC
2016
FIBROGEN INCENTIVECOMPENSATION PLAN
FIBROGEN INC
2016
FibroGen, Inc. Non-Employee Director Compensation Policy Adopted: September 17, 2014 Amended: March 4, 2015 Amended: February 23, 2016, Effective as of the 2016 Annual Meeting of...
Compensation Agreements
FIBROGEN INC
Biotechnology
2016
AMENDMENT NO. 15 TO THE PROCESS DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT
Development Agreements
FIBROGEN INC
2015
AMENDMENT NO. 16 TO THE PROCESS DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT
Development Agreements
FIBROGEN INC
2015
AMENDMENT NO.17 TOTHE PROCESS DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT
Development Agreements
FIBROGEN INC
Biotechnology
2015
Page 1 / 3
FIBROGEN INC
Biotechnology
2015
AMENDMENT NO.19 TO THE PROCESS DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT
Development Agreements
FIBROGEN INC
2015
AMENDMENT NO. 20 TO THE PROCESS DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT
Development Agreements
FIBROGEN INC
Biotechnology
2015
AMENDMENT NO. 21 TO THE PROCESS DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT
Development Agreements
FIBROGEN INC
Biotechnology
2015
AMENDMENT NO. 23 TO THE PROCESS DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT
Development Agreements
FIBROGEN INC
2015
FibroGen, Inc. Non-Employee Director Compensation Policy Adopted: September 17, 2014 Amended: March 4, 2015 Effective as of: The effective date of the initial public offering
Compensation Agreements
FIBROGEN INC
2015
AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (for the US and Certain Other Territories) between FIBROGEN, INC. and ASTRAZENECA AB
License Agreements
FIBROGEN INC
2014
FibroGen, Inc. CommonStock, par value $0.01 per share Underwriting Agreement
Underwriting Agreements
FIBROGEN INC
Biotechnology
DE
2014
FIBROGEN, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 09, 2014 APPROVED BY THE STOCKHOLDERS:SEPTEMBER 30, 2014 IPO DATE/EFFECTIVE DATE:[ ], 2014
Bonus & Incentive Agreements
FIBROGEN INC
2014
FIBROGEN, INC. 2014EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THEBOARD OF DIRECTORS: SEPTEMBER 09, 2014 APPROVEDBY THE STOCKHOLDERS: SEPTEMBER 30, 2014
Stock Agreements
FIBROGEN INC
Biotechnology
2014
FIBROGEN 2014 INCENTIVECOMPENSATION PLAN
FIBROGEN INC
2014
FIBROGEN, INC. 2014EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THEBOARD OF DIRECTORS: SEPTEMBER 09, 2014 APPROVEDBY THE STOCKHOLDERS: SEPTEMBER 30, 2014
Stock Agreements
FIBROGEN INC
Biotechnology
2014
COMMON STOCK PURCHASEAGREEMENT
Stock Agreements
FIBROGEN INC
2014
FIBROGEN, INC. CHANGEIN CONTROL AND SEVERANCE AGREEMENT
Change of Control Agreements
FIBROGEN INC
2014
INDEMNITY AGREEMENT
FIBROGEN INC
2014
AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (CHINA) between FIBROGEN CHINA ANEMIA HOLDINGS, LTD.; BEIJING FIBROGEN MEDICAL TECHNOLOGY DEVELOPMENT...
License Agreements
FIBROGEN INC
Biotechnology
CA
2014
FibroGen, Inc. Non-Employee Director Compensation Policy Adopted: September 17, 2014 Effective as of: The effective date of the initial public offering
Compensation Agreements
FIBROGEN INC
2014
AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (for the US and Certain Other Territories) between FIBROGEN, INC. and ASTRAZENECA AB
License Agreements
FIBROGEN INC
Biotechnology
CA
2014
INVESTORS RIGHTS AGREEMENT
Investor Rights Agreements
FIBROGEN INC
2014
INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
FIBROGEN INC
Biotechnology
DE
2014
INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
FIBROGEN INC
2014